Subscribe to our Newsletters !!
Infections pose an everpresent threat to society a
Eppendorf, a leading international life science co
The Nobel Prize in Physiology or Medicine awarded
Giesen, Germany. 26 January 2026 - At Interpack 20
Alembic Pharmaceuticals Limited (Alembic) today an
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Micr
AstraZeneca Plc said on Friday clinical trials of its experimental COVID-19 vaccine declared in Japan, while adding that it was in talks with regulators on data necessary to restart studies in the United States, where they remain halted.
Several global trials of the vaccine, AZD1222, were put on hold last month after an unexplained illness in a study participant. Although most trials have resumed, U.S. trials continue to be on pause as regulators widened their probe, Reuters reported on Wednesday.
While most trials have resumed, U.S. trials are still on pause as regulators widened their probe, Reuters reported on Wednesday.
The British drugmaker said the early-to-mid-stage trial for the vaccine candidate against the novel coronavirus resumed in Japan after consultations with the federal health regulator, the Japanese Pharmaceuticals and Medical Devices Agency.
Trials in Britain, Brazil, South Africa and India had already declared.